Business · 31/05/2022Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting to Discuss COVID-19 Vaccine Strain Composition
Summary
The FDA is hosting a public advisory committee meeting to gather input on modifying the SARS-CoV-2 strain composition of COVID-19 vaccines, with public comments accepted through a newly established docket.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →